Taichi for Overweight/Obese Adolescent and Young Women With Polycystic Ovary Syndrome (PCOS)
Not Applicable
- Conditions
- Polycystic Ovary Syndrome
- Interventions
- Behavioral: TaichiBehavioral: Self-monitored exercise
- Registration Number
- NCT02608554
- Lead Sponsor
- Heilongjiang University of Chinese Medicine
- Brief Summary
The present study is a randomized pilot study, overweight/obese adolescent and young PCOS subjects will be assigned into two groups: Taichi arm and control arm. Hormonal profile and metabolic profile will be determined.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 50
Inclusion Criteria
- Women aged between 19 and 35 years;
- Diagnosis of PCOS according to the modified Rotterdam criteria;
- 2 years after menarche;
- Body mass index (BMI) equal to or greater than 23 kg/m*m.
Exclusion Criteria
- Administration of other medications known to affect reproductive function or metabolism within the past three months, including oral contraceptives, Gonadotropin-releasing hormone (GnRH) agonists and antagonists, anti androgens, gonadotropins, anti-obesity drugs, Chinese herbal medicines, anti diabetic drugs such as metformin and thiazolidinediones, somatostatin, diazoxide, and calcium channel blockers.
- Patients with other endocrine disorder including 21-hydroxylase deficiency, hyperprolactinemia, uncorrected thyroid disease, suspected Cushing's syndrome.
- Patients with known severe organ dysfunction or mental illness.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Taichi Taichi The 24 forms of simplified TCC recommended as the popular health sport by the General Administration of Sport of China were applied. Self-monitored exercise Self-monitored exercise Exercise was self-monitored and consisted of brisk walking, cycling, jogging, or any other aerobic exercise.
- Primary Outcome Measures
Name Time Method Body mass index (BMI) 3 months
- Secondary Outcome Measures
Name Time Method Testosterone (T) 3 months Follicle stimulating hormone (FSH) 3 months Fasting plasma glucose (Glu) 3 months Fasting insulin (Ins) 3 months HOMA-IR 3 months HOMA-IR = fasting insulin concentrations (mIU/L) ×fasting plasma glucose concentrations (mmol/L)/22.5
Ferriman-Gallwey score 3 months Luteinizing hormone (LH) 3 months Waist/hip ratio 3 months
Trial Locations
- Locations (1)
First Affiliated Hospital, Heilongjiang University of Chinese Medicine
🇨🇳Harbin, Heilongjiang, China